NYSE: KRC · Kilroy Realty Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $270.05M | - | $279.74M | $289.89M | $270.84M | - | $289.94M | $280.73M | $278.58M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $20.70M | - | $18.25M | $18.48M | $16.90M | - | $18.07M | $18.95M | $17.58M | - |
| Total Operating Expenses | $209.31M | - | $199.00M | $196.74M | $196.99M | - | $205.54M | $199.50M | $197.20M | - |
| D&A | $92.89M | - | $87.49M | $87.63M | $85.73M | - | $91.88M | $87.15M | $86.46M | - |
| Operating Income | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $38.51M | - | $32.15M | $30.84M | $38.87M | - | $29.84M | $26.38M | $38.87M | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | ($19.27M) | - | $156.22M | $68.45M | $39.01M | - | $52.38M | $49.21M | $49.92M | - |
| EPS - Basic | ($0.16) | - | $1.32 | $0.58 | $0.33 | - | $0.44 | $0.41 | $0.42 | - |
| EPS - Diluted | ($0.16) | - | $1.31 | $0.57 | $0.33 | - | $0.44 | $0.41 | $0.42 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $192.90M | $179.32M | $372.42M | $193.13M | $146.71M | $165.69M | $625.39M | $835.89M | $855.01M | $510.16M |
| Accounts Receivable | $15.71M | $12.77M | $13.19M | $11.72M | $11.68M | $11.03M | $11.22M | $10.23M | $13.29M | $13.61M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $10.77B | $10.92B | $10.99B | $10.87B | $10.88B | $10.90B | $11.38B | $11.54B | $11.60B | $11.40B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $5.29B | $5.28B | $5.31B | $5.27B | $5.30B | $5.29B | $5.77B | $5.91B | $5.96B | $5.74B |
| Stockholders' Equity | $5.27B | $5.42B | $5.47B | $5.37B | $5.36B | $5.38B | $5.38B | $5.41B | $5.41B | $5.43B |
| Retained Earnings | $102.86M | $188.88M | $240.81M | $148.95M | $144.87M | $171.21M | $175.96M | $187.80M | $203.08M | $221.15M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $150.69M | - | - | - | $136.92M | - | - | - | $167.87M | - |
| Investing Cash Flow | $15.05M | - | - | - | ($76.66M) | - | - | - | $76.85M | - |
| Financing Cash Flow | ($152.16M) | - | - | - | ($79.24M) | - | - | - | $100.13M | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | -7.1% | - | 55.8% | 23.6% | 14.4% | - | 18.1% | 17.5% | 17.9% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 7.7% | - | 6.5% | 6.4% | 6.2% | - | 6.2% | 6.8% | 6.3% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -0.2% | - | 1.4% | 0.6% | 0.4% | - | 0.5% | 0.4% | 0.4% | - |
| Return on equity | -0.4% | - | 2.9% | 1.3% | 0.7% | - | 1.0% | 0.9% | 0.9% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 2.05 | 2.01 | 2.01 | 2.03 | 2.03 | 2.02 | 2.12 | 2.14 | 2.14 | 2.10 |
| Liabilities / Assets | 0.49 | 0.48 | 0.48 | 0.49 | 0.49 | 0.49 | 0.51 | 0.51 | 0.51 | 0.50 |
| Efficiency | ||||||||||
| Asset turnover | 0.03 | - | 0.03 | 0.03 | 0.02 | - | 0.03 | 0.02 | 0.02 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 21d | - | 17d | 15d | 16d | - | 14d | 13d | 17d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -0.3% | - | -3.5% | 3.3% | -2.8% | - | 2.2% | -1.2% | -4.9% | - |
| Revenue CAGR (3y) | -2.7% | - | 0.5% | 2.2% | 0.7% | - | 7.7% | 7.5% | 5.7% | - |
| Revenue CAGR (5y) | 2.8% | - | 4.1% | 5.7% | 4.1% | - | 6.1% | 7.0% | 6.7% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | - | - | 198.3% | 39.1% | -21.9% | - | -0.7% | -11.5% | -11.8% | - |
| EPS growth (YoY) | - | - | 197.7% | 39.0% | -21.4% | - | -2.2% | -12.8% | -12.5% | - |
| EPS CAGR (3y) | - | - | 24.4% | 12.5% | -9.8% | - | 3.2% | 11.0% | -53.8% | - |
| EPS CAGR (5y) | - | - | 25.5% | 27.4% | -2.3% | - | 1.4% | 0.0% | 3.1% | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -1.7% | 0.7% | 1.6% | -0.7% | -1.0% | -0.8% | -1.0% | -0.5% | -0.4% | -0.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$19.08M totalOffice And Life Science Properties Segment$19.08M · 100.0%
Peer comparison
Same SIC group: Real Estate Investment Trusts
Comparing KILROY REALTY CORP against the 5 most active filers in the same SIC group.